Osteoporosis.  2011 Aug;9(2):193-198.

The Change of Urine Deoxypyridinoline in a Patient with Symptomatic Hypercalcemia associated with Hyperthyroidism

Affiliations
  • 1Department of Internal Medicine, College of Medicine, Chung-Ang University, Seoul, Koera. drahn@cau.ac.kr

Abstract

Malignancy and primary hyperparathyroidism are the common causes of hypercalcemia. Although hyperthyroidism may induce mild asymptomatic hypercalcemia, it is very rare that hyperthyroidism causes symptomatic hypercalcemia with a serum calcium concentration > or = 11 mg/dL. A 47-year-old woman visited our hospital for evaluation of nausea, vomiting, and urinary frequency. Her corrected total calcium level was 12.0 mg/dL. She was diagnosed with hyperthyroidism. We excluded the common causes of hypercalcemia by measurements of serum intact parathyroid hormone and a diagnostic work-up for malignancy. She was treated with propranolol and methimazole. The serum calcium and urine deoxypyridinoline, as a bone resorption marker, decreased and hypercalcemic symptoms resolved completely after restoration of the biochemical euthyroid state. In case of difficulty in excluding other causes of hypercalcemia in hyperthyroid patients, the follow-up of changes of bone turnover marker and level of serum calcium can be helpful.

Keyword

Hypercalcemia; Hyperthyroidism; Bone resorption marker; Deoxypyridinoline

MeSH Terms

Amino Acids
Bone Resorption
Calcium
Female
Follow-Up Studies
Humans
Hypercalcemia
Hyperparathyroidism, Primary
Hyperthyroidism
Methimazole
Middle Aged
Nausea
Parathyroid Hormone
Propranolol
Vomiting
Amino Acids
Calcium
Methimazole
Parathyroid Hormone
Propranolol
Full Text Links
  • OST
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr